Recordati Rare Diseases is part of the Recordati Group and is dedicated to developing innovative, high-impact therapies. Our focus is mainly on those who we believe need it most — people affected by rare diseases. They serve as our top priority and sit at the centre of everything we do.
Therapeutic areas of focus:
- Acute intermittent porphyria (AIP)
- Hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency, propionic acidemia (PA) and methylmalonic acidemia (MMA)
- Acromegaly & Cushing’s disease
- Cystinosis
- Homocystinuria
- Mycosis fungoides-type cutaneous T-cell lymphoma (MF-type CTCL)
- Patent ductus arteriosus
- Wilms’ tumour
Get in touch by visiting https://www.recordatirarediseases.com/ca/contact-us
